| Affiliation: | 1. Vejle Hospital and University of Southern Denmark, Vejle, Denmark;2. Sarah Cannon Research Institute, University College London Cancer Institute, London, United Kingdom;3. Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy;4. Department of Hematology, UMC Utrecht Cancer Centre, Utrecht, The Netherlands;5. Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France;6. Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom;7. Hematology Department, University Hospital, Vandoeuvre Les Nancy, France;8. The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA;9. Genmab US Inc., Princeton, NJ, USA;10. Janssen Biologics, Leiden, The Netherlands;11. Janssen Research & Development, Shanghai, China;12. Janssen Research & Development, Spring House, PA, USA;13. Janssen Research & Development, Raritan, NJ, USA |
